Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07636759Recruiting

AI ECG Algorithm for Detecting LV Systolic Dysfunction

Role: collaborator

NCT07712952Completed

Validation of AI-Based Detection of Idiopathic Pulmonary Fibrosis in Serial Chest Radiographs: A Retrospective Longitudinal Study

Role: collaborator

NCT07686562Completed

Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography

Role: collaborator

NCT07378956Not ApplicableRecruiting

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

Role: lead

NCT07515859Completed

Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

Role: collaborator

NCT06713226Not ApplicableWithdrawn

Clinical Performance Evaluation of the Hativ P30

Role: lead

NCT04951973Unknown

Deep Learning Based Early Warning Score in Rapid Response Team Activation

Role: collaborator

All 7 trials loaded